<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6526">
  <stage>Registered</stage>
  <submitdate>9/11/2016</submitdate>
  <approvaldate>9/11/2016</approvaldate>
  <nctid>NCT02962674</nctid>
  <trial_identification>
    <studytitle>ProstaCare Study for BPH</studytitle>
    <scientifictitle>ProstaCare Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CIP# PC 1.0</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Benign Prostatic Hyperplasia</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - ProstaCare System

Other: Treatment - 


Treatment: devices: ProstaCare System


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Device-related SAE</outcome>
      <timepoint>12 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Improvement in BPH Symptoms</outcome>
      <timepoint>3 months</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Key 

          -  Enrolled subjects must be at least 45 years of age, diagnosed with BPH requiring
             intervention.

          -  Subject must have symptoms and uroflowmetry results characteristic of BPH.

          -  Prostate must be of sufficient size to accommodate study device.

        Key</inclusivecriteria>
    <inclusiveminage>45</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Male</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Urethral morphology unable to accommodate study device.

          -  Active urinary tract infection.

          -  Interest in maintaining fertility.

          -  Past history of surgical intervention for BPH.

          -  History or current medical conditions contraindicating elective urological procedures.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/09/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/06/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Tauranga</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state>Singapore</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>ProstaCare Singapore Pte. Ltd.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to evaluate the safety and performance of the ProstaCare System
      in relieving symptoms of urinary outflow obstruction secondary to benign prostatic
      hyperplasia.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02962674</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Henry Ho Sun Sien, MD</name>
      <address>Singapore General Hospital</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Annegret Genger, BME</name>
      <address />
      <phone />
      <fax />
      <email>annegret.genger@seleon.de</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>